Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 409.0 | 245.3 | 136.4 | 65.9 |
| Revenue growth | 66.8% | 79.9% | 107.1% | |
| Cost of goods sold | 250.9 | 153.8 | 92.9 | 47.2 |
| Gross profit | 158.2 | 91.4 | 43.5 | 18.7 |
| Gross margin | 38.7% | 37.3% | 31.9% | 28.3% |
| Sales and marketing | 206.1 | 104.7 | 9.8 | 4.6 |
| Research and development | 81.2 | 29.8 | 15.4 | 12.0 |
| General and administrative | 60.2 | 22.6 | 9.8 | 7.0 |
| EBITA | -161.5 | -65.7 | 8.4 | -5.0 |
| EBITA margin | -39.5% | -26.8% | 6.2% | -7.5% |
| Amortization of intangibles | 27.8 | | | |
| EBIT | -189.3 | -65.7 | 8.4 | -5.0 |
| EBIT margin | -46.3% | -26.8% | 6.2% | -7.5% |
| Pre-tax income | -201.4 | -74.2 | 4.1 | -7.5 |
| Income taxes | -6.0 | 0.7 | 0.2 | 0.0 |
| Tax rate | 3.0% | | 3.9% | |
| Net income | -195.4 | -74.9 | 0.7 | -7.5 |
| Net margin | -47.8% | -30.6% | 0.5% | -11.5% |
| |
| Diluted EPS | ($1.24) | ($0.74) | $0.03 | ($0.38) |
| Shares outstanding (diluted) | 157.7 | 101.7 | 28.6 | 19.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|